Provectus Biopharmaceuticals, Inc.
What this means
- Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$6.3M (XBRL data filed with the SEC).
- Revenue downRevenue fell from $617K in 2024 to $336K in 2025 (46% lower).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $336K | $617K |
| Net income (loss) | $5.5M | $4.8M |
| Total assets | $698K | $1M |
| Total liabilities | $7M | $7M |
| Stockholders’ equity | −$6.3M | −$6M |
| Cash and equivalents | $251K | $307K |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- PROVECTUS BIOPHARMACEUTICALS, INC.
Formerly: Provectus Pharmaceuticals Inc - CIK
- 0000315545
- Tickers
- PVCT
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Knoxville, Tennessee
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 10, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 10-Q · filed Aug 13, 2026 · filing
- Form 8-K · items 5.02 · filed Jul 1, 2026 · filing
- Form 10-Q · filed May 14, 2026 · filing
- Form 10-K · filed Mar 26, 2026 · filing
- Form SCHEDULE 13D · filed Dec 8, 2025 · filing
- Form 10-Q · filed Nov 13, 2025 · filing
- Form 10-Q · filed Aug 14, 2025 · filing
- Form 10-Q · filed May 14, 2025 · filing
- Form 8-K · items 4.01, 9.01 · filed Apr 16, 2025 · filing
- Form 10-K · filed Mar 28, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Dec 5, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 5.02 · filed Aug 19, 2024 · filing
- Form 10-Q · filed Aug 13, 2024 · filing
- Form D · items 06b · filed Jul 17, 2024 · filing
- Form SC 13D · filed Jul 3, 2024 · filing
- Form 10-Q · filed May 14, 2024 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 16, 2024 · filing
- Form 10-K · filed Mar 28, 2024 · filing
- Form 8-K · items 5.02, 9.01 · filed Mar 26, 2024 · filing
- Form 10-Q · filed Nov 14, 2023 · filing
- Form 10-Q · filed Aug 14, 2023 · filing
- Form 10-Q · filed May 11, 2023 · filing
- Form 10-K · filed Mar 30, 2023 · filing